anti-beta-sheet conformational mAbs (New York University School of Medicine)

N/A

Report date: 2025/01/26 16:13:47

Base Information

Drug Nameanti-beta-sheet conformational mAbs (New York University School of Medicine)
Drug Alias NameGW-23B7
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsMicrotubule-associated protein tau inhibitors
TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesNew York University School Of Medicine
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A